Lumira Capital Investment Management Inc.

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 47% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Lumira Capital Investment Management Inc.'s trades of Edesa Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
139.73
Quantity 14,337 +2.4%
Value US$2,842,276
Transaction date
Sale
Price
159.02
Quantity 23,123 -17.6%
Value US$481,217
Transaction date
Sale
Price
351.36
Quantity 44,652 -21.8%
Value US$2,748,683
Transaction date
Sale
Price
2.66
Quantity 12,284 -7.0%
Value US$32,701
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-12 2023-01-10
S Sale
14,337 +2.4%
139.73
US$2,842,276 		14,337 +2.4% 139.73 US$2,842,276
2023-01-12 2023-01-10
S Sale
23,123 -17.6%
159.02
US$481,217 		23,123 -17.6% 159.02 US$481,217
2023-01-12 2023-01-09
S Sale
44,652 -21.8%
351.36
US$2,748,683 		44,652 -21.8% 351.36 US$2,748,683
2023-01-12 2023-01-09
S Sale
12,284 -7.0%
2.66
US$32,701 		12,284 -7.0% 2.66 US$32,701